Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jennifer Gaultney"'
Autor:
Spyros Kolovos, Leana Bellanca, Harinala Groyer, Giuseppe M.C. Rosano, Alexandra Solé, Jennifer Gaultney, Stephan Linden
Publikováno v:
ESC Heart Failure, Vol 10, Iss 6, Pp 3385-3397 (2023)
Abstract Aims Heart failure is a chronic progressive condition, with considerable burden on patients' quality of life and economic burden for the healthcare systems. Before the approval of empagliflozin, there were no proven effective treatments for
Externí odkaz:
https://doaj.org/article/47d66ea7e2344e5e96c1b2e9db40f2eb
Autor:
Teresa L Kauf, Vimalanand S. Prabhu, Goran Medic, Rebekah H. Borse, Benjamin Miller, Jennifer Gaultney, Shuvayu S. Sen, Anirban Basu
Publikováno v:
BMC Infectious Diseases, Vol 17, Iss 1, Pp 1-10 (2017)
Abstract Background A challenge in the empiric treatment of complicated urinary tract infection (cUTI) is identifying the initial appropriate antibiotic therapy (IAAT), which is associated with reduced length of stay and mortality compared with initi
Externí odkaz:
https://doaj.org/article/516ae7d500cd4088b43d7042f269d902
Autor:
Edel Falla, Jennifer Gaultney
Publikováno v:
International Journal of Technology Assessment in Health Care. 38:S96-S97
IntroductionThe recent National Institute for Health and Care Excellence (NICE) consultation on methods for health technology evaluation (HTE) outlined plans to include guidance on the role of real-world evidence (RWE) in HTE. This is particularly pe
Publikováno v:
International Journal of Technology Assessment in Health Care. 38:S26-S26
IntroductionResearch suggests a different willingness to pay for more effective interventions than willingness to accept (WTA) for less effective interventions which has prompted debate as to whether the threshold in the southwest (SW) quadrant shoul
Autor:
Jennifer Gaultney, Peter A.S. Johnstone, Joshua D. Lawson, Nabil F. Saba, William Grist, Lawrence W. Davis
Publikováno v:
American Journal of Otolaryngology. 30:244-249
Objectives Although intensified therapy has contributed to improved outcomes for patients with head and neck cancer, acute toxicity has increased as well. To lessen the severity of nutritional compromise in these patients, our institutional protocol